Biodesix Inc - Product Pipeline Analysis, 2018 Update

  • ID: 4239708
  • Company Profile
  • 32 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • CardioDx Inc
  • Foundation Medicine Inc
  • Roka Bioscience Inc
  • Xagenic Inc
  • MORE
Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine. These tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and also provide improved therapeutic guidance for cancer patients. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer; and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer. The company collaborates with leading researchers to develop companion diagnostics for use with therapeutic agents and work in partnership with biotechnology and pharmaceutical companies such as Aveo Oncology and Biognosys. Biodesix is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biodesix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • CardioDx Inc
  • Foundation Medicine Inc
  • Roka Bioscience Inc
  • Xagenic Inc
  • MORE
  • Biodesix Inc Company Overview
  • Biodesix Inc Company Snapshot
  • Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Biodesix Inc - Pipeline Analysis Overview
  • Biodesix Inc - Key Facts
  • Biodesix Inc - Major Products and Services
  • Biodesix Inc Pipeline Products by Development Stage
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
  • Biodesix Inc Pipeline Products Overview
  • GeneStrat
  • GeneStrat Product Overview
  • HRM-MS Based Companion Diagnostic Test
  • HRM-MS Based Companion Diagnostic Test Product Overview
  • PD-L1 Blood Based Diagnostic Test
  • PD-L1 Blood Based Diagnostic Test Product Overview
  • PD-L1 Blood Based Diagnostic Test Clinical Trial
  • TAm-Seq NGS Lung Cancer Test
  • TAm-Seq NGS Lung Cancer Test Product Overview
  • VeriStrat - Breast Cancer
  • VeriStrat - Breast Cancer Product Overview
  • VeriStrat - Colorectal Cancer
  • VeriStrat - Colorectal Cancer Product Overview
  • VeriStrat - NSCLC
  • VeriStrat - NSCLC Product Overview
  • VeriStrat - NSCLC Clinical Trial
  • Biodesix Inc - Key Competitors
  • Biodesix Inc - Key Employees
  • Biodesix Inc - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • Biodesix Inc, Recent Developments
  • Apr 30, 2018: New Data Demonstrate the Biodesix VeriStrat Liquid Biopsy Test Reliably Informs Lung Cancer Treatment Decisions
  • Apr 18, 2018: New Data Shows Biodesix Blood Test Reliably Detects Additional Mutations in Patients with NSCLC
  • Apr 05, 2018: Biodesix Announces Data To Be Presented at AACR Annual Meeting 2018
  • Dec 20, 2017: Data Published In AACR Journal Suggest Biodesix Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors
  • Dec 05, 2017: Biodesix Leaders Share Commercial and Pipeline Updates at Annual qPCR and dPCR Congress
  • Nov 16, 2017: Biodesix Announces New Data Demonstrating Analytic Validity of Automated RNA Extraction from Plasma with the GeneStratTest
  • Nov 01, 2017: Biodesix Blood-Based Diagnostic Testing Approach To PD-L1 Detection Shows Concordance with Immunohistochemistry
  • Oct 25, 2017: Biodesix To Present Data at SITC Annual Meeting
  • Oct 06, 2017: 2018 Preliminary Private Payor Rate-Based Payment Amounts Released for Clinical Diagnostic Laboratory Tests; Biodesix Commends CMS for Committing to On-Time PAMA Implementation
  • Sep 20, 2017: Study Published In Managed Care Regarding Prognostic and Cancer-Care Planning Value of Biodesix’s VeriStrat Proteomic Test
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Biodesix Inc Pipeline Products by Equipment Type
  • Biodesix Inc Pipeline Products by Indication
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
  • Biodesix Inc, Key Facts
  • Biodesix Inc, Major Products and Services
  • Biodesix Inc Number of Pipeline Products by Development Stage
  • Biodesix Inc Pipeline Products Summary by Development Stage
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
  • Biodesix Inc Ongoing Clinical Trials Summary
  • GeneStrat - Product Status
  • GeneStrat - Product Description
  • HRM-MS Based Companion Diagnostic Test - Product Status
  • HRM-MS Based Companion Diagnostic Test - Product Description
  • PD-L1 Blood Based Diagnostic Test - Product Status
  • PD-L1 Blood Based Diagnostic Test - Product Description
  • PD-L1 Blood Based Diagnostic Test - Concordance of Immunohistochemistry and a New Blood-based Expression Assay for the Detection of PD-L1 in Patients Diagnosed with Non-small Cell Lung Cancer
  • TAm-Seq NGS Lung Cancer Test - Product Status
  • TAm-Seq NGS Lung Cancer Test - Product Description
  • VeriStrat - Breast Cancer - Product Status
  • VeriStrat - Breast Cancer - Product Description
  • VeriStrat - Colorectal Cancer - Product Status
  • VeriStrat - Colorectal Cancer - Product Description
  • VeriStrat - NSCLC - Product Status
  • VeriStrat - NSCLC - Product Description
  • VeriStrat - NSCLC - An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects with Non-small Cell Lung Cancer
  • Biodesix Inc, Key Employees
  • Glossary
List of Figures
  • Biodesix Inc Pipeline Products by Equipment Type
  • Biodesix Inc Pipeline Products by Development Stage
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Xagenic Inc
  • CardioDx Inc
  • Roka Bioscience Inc
  • Foundation Medicine Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll